Stay updated on Pembrolizumab and Radiation in Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab and Radiation in Lung Cancer Clinical Trial page.
Latest updates to the Pembrolizumab and Radiation in Lung Cancer Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedAdded a Locations section listing Texas as a location and removed the previous Texas Locations entry.SummaryDifference0.2%
- Check22 days agoNo Change Detected
- Check29 days agoNo Change Detected
- Check43 days agoChange DetectedPublications section wording updated to say publications are automatically filled from PubMed and may not be about the study, and the revision version changed from v3.2.0 to v3.3.2.SummaryDifference0.1%
- Check50 days agoChange DetectedThe government funding lapse notice has been removed from the page, and the rest of the study details page remains unchanged.SummaryDifference0.3%
- Check64 days agoChange DetectedThe screenshots show formatting changes and last-updated date updates, with no changes to the study's primary objectives, inclusion/exclusion criteria, endpoints, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%
- Check86 days agoChange DetectedAdds several date entries (including future dates) and removes some past dates, indicating an update to time-related information without clear changes to core content or pricing.SummaryDifference0.3%
- Check93 days agoChange DetectedAdds a government-status notice and a new software version (v3.2.0); removes the old version tag (v3.1.0).SummaryDifference2%
Stay in the know with updates to Pembrolizumab and Radiation in Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Radiation in Lung Cancer Clinical Trial page.